Trastuzumab Completed Phase N/A Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01048099Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
NCT00896376Trastuzumab in Treating Women With Metastatic Breast Cancer